AbbVie Inc. Stock Forecast
Weaker technical forecast for AbbVie Inc. as stock downgraded to Sell Candidate.
(Updated on May 14, 2024)
The AbbVie Inc. stock price fell by -1.09% on the last day (Tuesday, 14th May 2024) from 150.30€ to 148.66€. During the last trading day the stock fluctuated 1.66% from a day low at 148.40€ to a day high of 150.86€. The price has been going up and down for this period, and there has been a -0.11% loss for the last 2 weeks. Volume has increased on the last day by 175 shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 649 shares were bought and sold for approximately 96.48€ thousand.
The stock lies in the middle of a falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -10.33% during the next 3 months and, with a 90% probability hold a price between 130.99€ and 138.37€ at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.
4AB.F Signals & Forecast
There are few to no technical positive signals at the moment. The AbbVie Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at 149.83€ and 155.93€. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Tuesday, April 23, 2024, and so far it has fallen -6.18%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). AbbVie Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs". The very low volume increases the risk and reduces the other technical signals issued.
Support, Risk & Stop-loss for AbbVie Inc. stock
There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.
This stock is usually traded at a good volume, and with minor daily changes, the risk is considered to be low. During the last day, the stock moved 2.46€ (1.66%) between high and low. For the last week, the stock has had daily average volatility of 1.00%.
Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.
Trading Expectations (4AB.F) For The Upcoming Trading Day Of Wednesday 15th
For the upcoming trading day on Wednesday, 15th we expect AbbVie Inc. to open at 149.31€, and during the day (based on 14 day Average True Range), to move between 146.20€ and 151.12€, which gives a possible trading interval of +/-2.46€ (+/-1.65%) up or down from last closing price. If AbbVie Inc. takes out the full calculated possible swing range there will be an estimated 3.30% move between the lowest and the highest trading price during the day.
With no support below and resistance from accumulated volume @ 148.82€, some 0.160€ (0.11%) from the current price of 148.66€, our system finds the risk reward not very attractive.
Is AbbVie Inc. stock A Buy?
AbbVie Inc. holds several negative signals and is within a falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.
Current score: -4.307 Sell Candidate Downgraded
Predicted Opening Price for AbbVie Inc. of Wednesday, May 15, 2024
| Fair opening price May 15, 2024 | Current price |
|---|---|
| 149.31€ ( 0.435%) | 148.66€ |
The predicted opening price is based on yesterday's movements between high, low, and closing price.
Trading levels for 4AB.F
Fibonacci Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 151.77 | 2.09 % | |
| R2 | 150.83 | 1.46 % | ||
| R1 | 150.25 | 1.07 % | ||
| Current price: | 148.66 | |||
| Support | S1 | 148.37 | -0.197 % | |
| S2 | 147.79 | -0.588 % | ||
| S3 | 146.85 | -1.22 % |
Accumulated Volume Support & Resistance Levels
| Level | Price | |||
|---|---|---|---|---|
| Resistance | R3 | 157.00 | 5.61 % | |
| R2 | 153.62 | 3.34 % | ||
| R1 | 148.82 | 0.108 % | ||
| Current price | 148.66 | |||
| Support | S1 | 0 | . | |
| S2 | 0 | . | ||
| S3 | 0 | . |
4AB Dividend Payout History
| # | Ex-Date | Pay Date | Amount | Yield | |
|---|---|---|---|---|---|
| 1 | Apr 12, 2024 | Apr 12, 2024 | May 15, 2024 | 1.44€ | 0% |
| 2 | Jan 15, 2024 | Jan 15, 2024 | Jan 15, 2024 | 0€ | 0% |
| 3 | Jan 12, 2024 | Jan 12, 2024 | Jan 12, 2024 | 0€ | 0% |
| 4 | Jul 13, 2023 | Jul 13, 2023 | Jul 13, 2023 | 1.48€ | 0% |
| 5 | Apr 13, 2023 | Apr 13, 2023 | Apr 13, 2023 | 1.48€ | 0% |
FAQ
Click here for our free guide on how to buy AbbVie Inc. Stock.
